Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark....More>>>
Walmart (NYSE:WMT) is one of the great business success stories of the past few decades. After revolutionizing American retailing in the 1980s and 1990s, it has managed to hold its own in this century even as so much consumer traffic has shifted to online spending. Walmart stock has been a steady, reliable grower as well.
The Arkansas-based company has dominated low- to mid-priced retailing....More>>>
This stock’s low price isn’t going to last forever — it’s time to get in while the getting’s good.
—Sponsored Link— Motley Fool Issues Rare Triple-Buy Alert
This three-time recommendation from the Motley Fool looks a lot like Berkshire in 1992. Click here to learn more.
One of the main goals of my premium newsletter High-Yield Investing....More>>>
It confounded the experts. Last month, a rare 1915 photo of legendary baseball great Babe Ruth was expected to fetch more than $50,000 at an online auction. Turns out that estimate was optimistic. In the end, the winning bidder paid just $39,000.
—Recommended Link— The Most Generous Income Producers You Can Get
We’re sitting on a collection of the safest, most generous....More>>>
Asia-Pacific equity markets struggled for direction after U.S. and European central bankers didnt provide fresh policy guidance, though Hong Kong stocks outperformed on strong corporate earnings.
Market participants were watching for implications from developments on U.S. tax policy, in addition to Hurricane Harveys impact on the global energy market. U.S. gasoline futures rose early Monday.Hot....More>>>
ContraVir Pharmaceuticals (CTRV) is a clinical-stage biotech company focused on the development of small-molecule antivirals for Chronic Hepatitis B. ContraVir has developed a strong Hepatitis B pipeline consisting of two small-molecule antiviral agents. With a novel cyclophilin inhibitor and a next-generation reverse transcriptase inhibitor, ContraVir hopes to become the first....More>>>
Very few hedge fund managers start with $2 billion from investor George Soros. One who did, Scott Bessent, has already given much of it back.
As Bessent has gathered capital since his firm’s 2016 launch, he has returned Soros’s money as part of an arrangement between the two, according to a person familiar with Soros’s family office who requested anonymity. Soros had....More>>>